Arrang J, Armand V
Pharmacol Res Perspect. 2024; 12(5):e1216.
PMID: 39376050
PMC: 11458884.
DOI: 10.1002/prp2.1216.
Yan M, Sun T, Liu J, Chang Q
J Neurol. 2024; 271(7):3942-3952.
PMID: 38782798
PMC: 11233303.
DOI: 10.1007/s00415-024-12453-7.
Jia R, Zhu G, Zhao R, Li T, Jiang W, Cui X
J Int Med Res. 2024; 52(3):3000605241235589.
PMID: 38546233
PMC: 10981235.
DOI: 10.1177/03000605241235589.
Daoud M, Durelle C, Fierain A, N E, Wendling F, Ruffini G
Brain Topogr. 2024; 37(5):897-906.
PMID: 38446345
DOI: 10.1007/s10548-024-01045-3.
Martin S, Leeman-Markowski B
Front Neurol. 2024; 14:1287545.
PMID: 38249745
PMC: 10797726.
DOI: 10.3389/fneur.2023.1287545.
Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.
Lumley L, Nguyen D, de Araujo Furtado M, Niquet J, Linz E, Schultz C
J Pharmacol Exp Ther. 2023; 388(2):347-357.
PMID: 37977809
PMC: 10801783.
DOI: 10.1124/jpet.123.001789.
Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
Nguyen D, Stone M, Schultz C, de Araujo Furtado M, Niquet J, Wasterlain C
J Pharmacol Exp Ther. 2023; 388(2):376-385.
PMID: 37770198
PMC: 10801769.
DOI: 10.1124/jpet.123.001784.
A modification to the Kuramoto model to simulate epileptic seizures as synchronization.
Zavaleta-Viveros J, Toledo P, Avendano-Garrido M, Escalante-Martinez J, Lopez-Meraz M, Ramos-Riera K
J Math Biol. 2023; 87(1):9.
PMID: 37329353
PMC: 10276802.
DOI: 10.1007/s00285-023-01938-0.
Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
Figueiredo T, Aroniadou-Anderjaska V, Apland J, Rossetti K, Braga M
Exp Biol Med (Maywood). 2023; 248(7):612-623.
PMID: 37300407
PMC: 10350803.
DOI: 10.1177/15353702231171911.
IRAK-M Ablation Promotes Status Epilepticus-Induced Neuroinflammation via Activating M1 Microglia and Impairing Excitatory Synaptic Function.
Liang X, Qian T, Xiong Y, Liang X, Ding Y, Zhu X
Mol Neurobiol. 2023; 60(9):5199-5213.
PMID: 37277682
DOI: 10.1007/s12035-023-03407-7.
A study on the clinical and electrographic profile of Nonconvulsive Status Epilepticus (NCSE) in comatose ICU patients using portable electroencephalography (EEG).
Anadure R, Goel J, Saxena R, Gupta S, Vidhale T
Med J Armed Forces India. 2023; 79(3):292-299.
PMID: 37193513
PMC: 10182287.
DOI: 10.1016/j.mjafi.2021.06.027.
Aminoprocalcitonin protects against hippocampal neuronal death via preserving oxidative phosphorylation in refractory status epilepticus.
Song C, Zhao J, Hao J, Mi D, Zhang J, Liu Y
Cell Death Discov. 2023; 9(1):144.
PMID: 37142587
PMC: 10160063.
DOI: 10.1038/s41420-023-01445-7.
The Role of Glutamate Receptors in Epilepsy.
Chen T, Huang T, Lai M, Huang C
Biomedicines. 2023; 11(3).
PMID: 36979762
PMC: 10045847.
DOI: 10.3390/biomedicines11030783.
The Roles of Glutamate Receptors and Their Antagonists in Status Epilepticus, Refractory Status Epilepticus, and Super-Refractory Status Epilepticus.
Huang T, Lai M, Chen Y, Huang C
Biomedicines. 2023; 11(3).
PMID: 36979664
PMC: 10045490.
DOI: 10.3390/biomedicines11030686.
Treatment of status epilepticus: Physiology, pharmacology, and future directions.
Sankar R
Epilepsia Open. 2023; 8 Suppl 1:S141-S148.
PMID: 36929735
PMC: 10173851.
DOI: 10.1002/epi4.12725.
Introduction to the special issue on status epilepticus: neuronal injury, plasticity, and therapies; Celebrating the legacy of Dr. Claude G. Wasterlain.
Engel Jr J, Moshe S, Nehlig A, Fujikawa D, Sankar R, Naylor D
Epilepsia Open. 2023; 8 Suppl 1:S7-S17.
PMID: 36929725
PMC: 10173845.
DOI: 10.1002/epi4.12724.
In the fast lane: Receptor trafficking during status epilepticus.
Naylor D
Epilepsia Open. 2023; 8 Suppl 1:S35-S65.
PMID: 36861477
PMC: 10173858.
DOI: 10.1002/epi4.12718.
Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
Niquet J, Nguyen D, de Araujo Furtado M, Lumley L
Epilepsia Open. 2023; 8 Suppl 1:S117-S140.
PMID: 36807554
PMC: 10173853.
DOI: 10.1002/epi4.12713.
Ketamine administration in idiopathic epileptic and healthy control dogs: Can we detect differences in brain metabolite response with spectroscopy?.
Wieser M, Beckmann K, Kutter A, Mauri N, Richter H, Zolch N
Front Vet Sci. 2023; 9:1093267.
PMID: 36686158
PMC: 9853535.
DOI: 10.3389/fvets.2022.1093267.
Why ketamine.
Coles L, Rosenthal E, Bleck T, Elm J, Zehtabchi S, Chamberlain J
Epilepsy Behav. 2023; 141:109066.
PMID: 36609129
PMC: 10073319.
DOI: 10.1016/j.yebeh.2022.109066.